Akanda Corp
NASDAQ:AKAN
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.45
5.5938
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| UK |
A
|
Akanda Corp
NASDAQ:AKAN
|
3m USD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
530.7B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
278.2B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
212.8B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
222.3B CHF |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.8T DKK |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
267.5B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
147B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
97.2B EUR |
Loading...
|
Market Distribution
| Min | -195 650% |
| 30th Percentile | 0% |
| Median | 0.1% |
| 70th Percentile | 0.2% |
| Max | 4 630.7% |
Other Profitability Ratios
Akanda Corp
Glance View
Akanda Corp. engages in cultivating cannabis. The firm is engaged in the cultivation, manufacturing, and distribution of cannabis. The firm cultivate and process natural cannabis at its facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower and cannabis concentrates to wholesalers in international markets. The firm also import and sell medical cannabis-based products to the domestic market in the United Kingdom. The Company’s subsidiaries include Bophelo Bio Science and Wellness (Pty) Limited, Canmart Limited, Bophelo Holdings Limited, and Cannahealth Limited. Bophelo Bio Science and Wellness (Pty) Limited is focused on the cultivation of cannabis, the production of medical cannabis products including dried flower, oils, and other concentrates. Canmart Limited is engaged in the production and sale of cannabis-based products for medicinal use.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Akanda Corp is -523.8%, which is above its 3-year median of -550%.
Over the last 1 years, Akanda Corp’s Operating Margin has decreased from -458.8% to -523.8%. During this period, it reached a low of -667.4% on Jun 30, 2024 and a high of -458.8% on Dec 1, 2023.